Cardinal Health's Pharma Chief Sold 7,354 Shares and Still Grew Her Stake by 47%. Here's How That Happened

Deborah Weitzman, CEO of Cardinal Health's PSS Segment, sold 7,354 shares for ~$1.7 million on August 18, 2026, but still increased her total stake by 47% after receiving performance units. Despite the sale, her direct holdings grew to 77,901 shares valued at $18.31 million. The Pharmaceutical and Specialty Solutions segment she leads showed strong performance with 6% revenue growth and 21% profit growth in Q4, with specialty business growing over 25% in fiscal 2026.